Appellate Tribunal reverses disallowance under Income Tax Act, recognizes ESOP expenses as deductible business costs.

The Appellate Tribunal allowed the appellant's appeal, overturning the disallowance under section 14A of the Income Tax Act and rejecting the addition of expenditure under ESOP to the appellant's income. The Tribunal emphasized the necessity of establishing a direct connection between expenditure and income for disallowance under section 14A and recognized ESOP expenses as deductible business costs.

---

---

Issues:
1. Disallowance u/s. 14A of the Act
2. Addition of expenditure under ESOP (Employee Stock Option Scheme)

Analysis:

Issue 1: Disallowance u/s. 14A of the Act
The appellant, a company engaged in executive search and consulting, challenged the disallowance of &8377; 2.74 lakhs under section 14A of the Income Tax Act. The Assessing Officer (AO) invoked Rule 8D of the Income Tax Rules, 1962, to make the disallowance based on the dividend income claimed by the appellant. The First Appellate Authority (FAA) upheld the AO's decision, citing the judgment of Godrej & Boyce Ltd. The Appellate Tribunal found that the AO did not specify the actual expenditure incurred for earning tax-free income and emphasized the need for a nexus between expenditure and income not forming part of total income. Relying on the case of Om Prakash Khaitan, the Tribunal reversed the FAA's order, stating that the AO must establish a connection between expenditure and non-taxable income. Ground No.1 was decided in favor of the appellant.

Issue 2: Addition of expenditure under ESOP
The AO added &8377; 56.40 lakhs to the appellant's income, alleging that the full amount debited under ESOP was not paid as Fringe Benefit Tax (FBT). The appellant argued that ESOP expenses and FBT payment were distinct concepts, and the FBT liability arises upon ESOP vesting in employees. The Tribunal noted that the appellant had paid FBT on a portion of the ESOP amount and treated the ESOP expenditure as compensation cost. Relying on precedents like Biocon Ltd. and Novo Nordisk India Pvt. Ltd., the Tribunal held that once stock options are exercised, the liability is ascertained, and the cost is allowable in the same year. Following the decision in Novo Nordisk India Pvt. Ltd., the Tribunal decided Ground No.2 in favor of the appellant.

In conclusion, the appeal filed by the appellant was allowed by the Appellate Tribunal, emphasizing the importance of establishing a direct link between expenditure and income for disallowance under section 14A and recognizing ESOP expenses as deductible business costs.

---